Hormonal therapy of breast cancer: State of the art Journal Article


Authors: Murphy, B.; Muss, H. B.
Article Title: Hormonal therapy of breast cancer: State of the art
Abstract: Hormonal therapy has an established role in the treatment of women with metastatic breast cancer and also is now a major component of adjuvant systemic therapy for those with early-stage disease. Moreover, recent data suggest that hormonal agents may have a potential use in the prevention of breast cancer in high-risk groups. This article will provide a general overview of the current roles of hormonal therapy and describe future directions that show particular promise.
Keywords: prednisone; review; chemotherapy, adjuvant; metastasis; breast cancer; transforming growth factor beta; estrogen; estrogens; breast neoplasms; risk factor; goserelin; leuprorelin; drug mechanism; tamoxifen; forecasting; diethylstilbestrol; hormonal therapy; aminoglutethimide; antiandrogen; antineoplastic agents, hormonal; anastrozole; growth factor; transforming growth factor alpha; fulvestrant; megestrol acetate; medroxyprogesterone acetate; toremifene; raloxifene; fluoxymesterone; estrogen antagonists; humans; human; female; buserelin; n butyl 11 (3,17beta dihydroxyestra 1,3,5(10) trien 7alpha yl) n methylundecanamide; idoxifene; droloxifene; miproxifene phosphate; trioxifene; zindoxifene
Journal Title: Oncology (Norwalk)
Volume: 11
Issue: 5 Suppl. 4
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 1997-05-01
Start Page: 7
End Page: 13
Language: English
PUBMED: 9165500
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 17 March 2017 -- Source: Scopus
Citation Impact